Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
92.89
-1.10 (-1.17%)
May 5, 2025, 4:00 PM EDT - Market closed

Revvity Market Cap

Revvity has a market cap or net worth of $11.16 billion as of May 5, 2025. Its market cap has decreased by -10.15% in one year.

Market Cap
11.16B
Enterprise Value
13.34B
1-Year Change
-10.15%
Ranking
Category
Stock Price
$92.89

Market Cap Chart

Since December 1, 1998, Revvity's market cap has increased from $1.28B to $11.16B, an increase of 770.08%. That is a compound annual growth rate of 8.53%.

History

DateMarket Cap% Change
May 2, 202511.30B-16.84%
Dec 31, 202413.58B0.69%
Dec 29, 202313.49B-23.84%
Dec 30, 202217.71B-30.20%
Dec 31, 202125.37B57.91%
Dec 31, 202016.07B48.95%
Dec 31, 201910.79B23.46%
Dec 31, 20188.74B8.41%
Dec 29, 20178.06B41.08%
Dec 30, 20165.71B-4.73%
Dec 31, 20156.00B21.39%
Dec 31, 20144.94B6.60%
Dec 31, 20134.63B27.20%
Dec 31, 20123.64B61.08%
Dec 30, 20112.26B-25.79%
Dec 31, 20103.05B26.77%
Dec 31, 20092.40B46.34%
Dec 31, 20081.64B-46.73%
Dec 31, 20073.08B12.83%
Dec 29, 20062.73B-11.29%
Dec 30, 20053.08B6.97%
Dec 31, 20042.88B33.04%
Dec 31, 20032.17B107.75%
Dec 31, 20021.04B-70.73%
Dec 31, 20013.56B-32.07%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 739.39B
Johnson & Johnson 375.64B
UnitedHealth Group 364.02B
AbbVie 351.09B
Novo Nordisk 307.48B
Abbott Laboratories 231.09B
Novartis AG 223.50B
AstraZeneca 221.69B
Market Cap Rankings